ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden · Delayed Price · Currency is SEK 1.030
-0.060 (-5.50%)
Oct 14, 2026, 5:29 PM CET
STO:EXPRS2 Market Cap
STO:EXPRS2 has a market cap or net worth of 24.46 million as of October 14, 2026. It is the 47,293rd most valuable company in the world and the 739th biggest in Sweden. Its market cap has decreased by 64.43% in one year.
Market Cap
24.46M
Enterprise Value
-8.46M
Revenue
24.25M
Global Rank
Country Rank
#739 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since July 29, 2016, STO:EXPRS2's market cap has decreased from 117.71M to 24.46M, a decrease of -79.22%. That is a compound annual growth rate of -14.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 24.46M | -56.42% |
| Dec 30, 2025 | 56.13M | 29.73% |
| Dec 30, 2024 | 43.27M | -60.11% |
| Dec 29, 2023 | 108.46M | -82.55% |
| Dec 30, 2022 | 621.64M | -45.72% |
| Dec 30, 2021 | 1.15B | 280.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Spago Nanomedical AB | 83.03M |
| Nanologica AB | 82.85M |
| Ascelia Pharma AB | 81.46M |
| Pila Pharma AB | 75.38M |
| AcouSort AB | 75.34M |
| Annexin Pharmaceuticals AB | 71.66M |
| Modus Therapeutics Holding AB | 53.98M |
| Fluicell AB | 37.78M |